About Vosoritide
Class: | Peptide-based therapy (growth hormone analog)
Use: | Treatment of achondroplasia in pediatric patients aged 2 years and older
Adult dose: | Not applicable; indicated for pediatric use only
Pediatric dose: | 0.56 mg/kg subcutaneously once daily; maximum dose of 2.5 mg per day
Side effects: | Injection site reactions, headache, nausea, diarrhea, fatigue, and elevated liver enzymes
Contraindications: | Hypersensitivity to vosoritide or any component of the formulation; pregnancy
Drug Class
Peptide-based therapy (growth hormone analog)
Uses & Indications
Treatment of achondroplasia in pediatric patients aged 2 years and older
Storage Requirements
Store in the refrigerator (2°C to 8°C); do not freeze; protect from light; may be stored at room temperature (up to 25°C) for up to 30 days after reconstitution
Manufacturer & Packaging
Manufacturer: BioMarin International Limited, IRELAND
Package Size
(Powder Vial 0.56mg x 10's )+ (0.7ml Solvent Syringe x 10's)
Price & Supplier
Price in UAE: AED 26302.50
Dosage Information
Adult Dose
Not applicable; indicated for pediatric use only
Pediatric Dose
0.56 mg/kg subcutaneously once daily; maximum dose of 2.5 mg per day
Side Effects
Injection site reactions, headache, nausea, diarrhea, fatigue, and elevated liver enzymes
Contraindications & Precautions
Hypersensitivity to vosoritide or any component of the formulation; pregnancy (not studied in pregnant women)
Important Warnings
Risk of hypersensitivity reactions; monitor for signs of allergic reactions; not recommended for use in patients with severe renal impairment or liver disease; long-term effects on growth and development are not fully established
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.